Tianjin Chase Sun Pharmaceutical Co.,Ltd announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 6,488.115 million compared to CNY 5,002.938 million a year ago. Operating income was CNY 654.110 million compared to CNY 483.249 million a year ago. Net income was CNY 573.394 million compared to CNY 402.529 million a year ago. Basic earnings per share from continuing operations was CNY 0.19 compared to CNY 0.14 a year ago.